Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: Neuroprotective or neurotoxic properties of sirtuins in ALS?

Neurodegenerative Diseases

Volumn 11, Issue 3, 2013, Pages 141-152

  Körner, Sonja ^a   Böselt, Sebastian ^a   Thau, Nadine ^a,b   Rath, Klaus Jan ^a   Dengler, Reinhard ^a,b   Petri, Susanne ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Amyotrophic lateral sclerosis; In situ hybridization; Sirtuins

Indexed keywords

MESSENGER RNA; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; SIRTUIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CADAVER; CASE REPORT; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOTONEURON; NERVE CELL DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REDUCTION; SPINAL CORD DORSAL HORN; SPINAL CORD VENTRAL HORN; TISSUE HOMOGENATE; UPREGULATION; WHITE MATTER; AUTOPSY; SPINAL CORD; WESTERN BLOTTING;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; NEUROPROTECTIVE AGENTS; SIRTUIN 1; SIRTUIN 2; SIRTUINS; SPINAL CORD;

EID: 84873096554     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000338048     Document Type: Article

References (40)

1. Rothstein JD: Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009; 65(SUPPL1):S3-S9
2. Wijesekera LC, Leigh PN: Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009; 4: 3
3. Rothstein JD: Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009; 65(SUPPL1):S3-S9
4. Yoshihara T, Ishigaki S, Yamamoto M, Liang Y, Niwa J, Takeuchi H, Doyu M, Sobue G: Differential expression of inflammationand apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 2002; 80: 158-167
5. Ishigaki S, Niwa J, Ando Y, Yoshihara T, Sawada K, Doyu M, Yamamoto M, Kato K, Yotsumoto Y, Sobue G: Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords - Screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett 2002; 531: 354-358
6. Petri S, Kiaei M, Kipiani K, Chen J, Calingasan NY, Crow JP, Beal MF: Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2006; 22: 40-49
7. Schmalbach S, Petri S: Histone deacetylation and motor neuron degeneration. CNS Neurol Disord Drug Targets 2010; 9: 279-284
8. Kazantsev AG, Thompson LM: Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 2008; 7: 854-868
9. Ryu H, Smith K, Camelo SI, Carreras I, Lee J, Iglesias AH, Dangond F, Cormier KA, Cudkowicz ME, Brown RH Jr, Ferrante RJ: Sodium phenylbutyrate prolongs survival and regulates expression of anti-Apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J Neurochem 2005; 93: 1087-1098
10. Broide RS, Redwine JM, Aftahi N, Young W, Bloom FE, Winrow CJ: Distribution of histone deacetylases 1-11 in the rat brain. J Mol Neurosci 2007; 31: 47-58
11. Janssen C, Schmalbach S, Boeselt S, Sarlette A, Dengler R, Petri S: Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2010; 69: 573-581
12. Gan L, Mucke L: Paths of convergence: Sirtuins in aging and neurodegeneration. Neuron 2008; 58: 10-14
13. Kaeberlein M, McVey M, Guarente L: The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 1999; 13: 2570-2580
14. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH: SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 2007; 26: 3169-3179
15. Julien C, Tremblay C, Emond V, Lebbadi M, Salem N Jr, Bennett DA, Calon F: Sirtuin-1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 2009; 68: 48-58
16. Wisden W, Gundlach AL, Barnard EA, Seeburg PH, Hunt SP: Distribution of GABA A receptor subunit mRNAs in rat lumbar spinal cord. Brain Res Mol Brain Res 1991; 10: 179-183
17. Petri S, Krampfl K, Hashemi F, Grothe C, Hori A, Dengler R, Bufler J: Distribution of GABA A receptor mRNA in the motor cortex of ALS patients. J Neuropathol Exp Neurol 2003; 62: 1041-1051
18. Southwood CM, Peppi M, Dryden S, Tainsky MA, Gow A: Microtubule deacetylases, SirT2 and HDAC6, in the nervous system. Neurochem Res 2007; 32: 187-195
19. Pandithage R, Lilischkis R, Harting K, Wolf A, Jedamzik B, Luscher-Firzlaff J, Vervoorts J, Lasonder E, Kremmer E, Knoll B, Luscher B: The regulation of SIRT2 function by cyclin-Dependent kinases affects cell motility. J Cell Biol 2008; 180: 915-929
20. Li W, Zhang B, Tang J, Cao Q, Wu Y, Wu C, Guo J, Ling EA, Liang F: Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating -Tubulin. J Neurosci 2007; 27: 2606-2616
21. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I: Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 2005; 16: 4623-4635
22. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y: Nucleocytoplasmic shuttling of the NAD+-Dependent histone deacetylase SIRT1. J Biol Chem 2007; 282: 6823-6832
23. Li Y, Xu W, McBurney MW, Longo VD: SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab 2008; 8: 38-48
24. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, Chua KF: Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-Deficient mice. Proc Natl Acad Sci USA 2003; 100: 10794-10799
25. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME: Stress-Dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011-2015
26. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W: Negative control of p53 by Sir2 promotes cell survival under stress. Cell 2001; 107: 137-148
27. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P: Nutrient control of glucose homeostasis through a complex of PGC-1 and SIRT1. Nature 2005; 434: 113-118
28. Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J. Sirtuins: The 'magnificent seven', function, metabolism and longevity. Ann Med 2007; 39: 335-345
29. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, Tsokos M, Alt FW, Finkel T: A role for the NAD-Dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA 2008; 105: 3374-3379
30. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA: Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305: 390-392
31. Rogina B, Helfand SL: Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci USA 2004; 101: 15998-16003
32. Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Neri C: Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 2005; 37: 349-350
33. Pallos J, Bodai L, Lukacsovich T, Purcell JM, Steffan JS, Thompson LM, Marsh JL: Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease. Hum Mol Genet 2008; 17: 3767-3775
34. Catoire H, Pasco MY, Abu-Baker A, Holbert S, Tourette C, Brais B, Rouleau GA, Parker JA, Neri C: Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. Hum Mol Genet 2008; 17: 2108-2117
35. Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, Franco S, Kaushal D, Cheng HL, Fischer MR, Stokes N, Murphy MM, Appella E, Alt FW: Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab 2005; 2: 67-76
36. Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA: Role for human SIRT2 NAD-Dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol 2003; 23: 3173-3185
37. Pfister JA, Ma C, Morrison BE, D'Mello SR: Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS One 2008; 3:e4090
38. Luthi-Carter R, Taylor DM, Pallos J, Lambert E, Amore A, Parker A, Moffitt H, Smith DL, Runne H, Gokce O, Kuhn A, Xiang Z, Maxwell MM, Reeves SA, Bates GP, Neri C, Thompson LM, Marsh JL, Kazantsev AG: SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci USA 2010; 107: 7927-7932
39. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet JC, McLean PJ, Young AB, Abagyan R, Feany MB, Hyman BT, Kazantsev AG: Sirtuin-2 inhibitors rescue -synuclein-mediated toxicity in models of Parkinson's disease. Science 2007; 317: 516-519
40. Barber SC, Higginbottom A, Mead RJ, Barber S, Shaw PJ: An in vitro screening cascade to identify neuroprotective antioxidants in ALS. Free Radic Biol Med 2009; 46: 1127-1138